India In Vitro Diagnostics Market to Hit USD 10.0 Billion (CAGR 6.84%) by 2033 | Request Free Sample Report

According to IMARC Group's report titled "India In Vitro Diagnostics Market Size, Share, Trends and Forecast by Test Type, Product, Usability, Application, End User, and Region, 2025-2033" the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

Market Size & Future Growth Potential:

The India in vitro diagnostics market size reached USD 5.3 Billion in 2024 and expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate of 6.84% during 2025-2033. The growth is driven by rising demand for accurate, early-stage disease detection and the growing burden of chronic and infectious illnesses across the country.

Note: We are in the process of updating our reports to cover the 2026-2034 forecast period. For the most recent data, insights, and industry updates, please click on 'Request Free Sample Report'.

Request Free Sample Report: https://www.imarcgroup.com/india-in-vitro-diagnostics-market/requestsample

Industry Key Highlights:

• Market Size in 2024: USD 5.3 Billion
• Expected Market Size by 2033: USD 10.0 Billion
• CAGR (2025-2033): 6.84%

• Key Market Drivers: Rising prevalence of chronic and infectious diseases, increasing demand for early diagnosis and preventive healthcare, growing adoption of advanced diagnostic technologies and expanding healthcare infrastructure.

• Growth Opportunities: Expansion of diagnostic services in tier-2 and tier-3 cities, growing demand for portable and point-of-care IVD kits, rising health awareness and preventive care adoption, supportive government initiatives boosting diagnostics penetration.

Recent News and Developments:

• September 2025: India launched the In-Vitro Diagnostics validation portal at the National Virus Research & Diagnostic Laboratory Conclave, a key initiative aimed at improving the efficiency and transparency of IVD validation processes. This portal, alongside new validation protocols developed by ICMR and CDSCO, is designed to strengthen India's diagnostic capabilities and enhance global competitiveness in the IVD market.

• August 2025: The Central Drugs Standard Control Organization and the Indian Council of Medical Research issued draft standard evaluation protocols for IVDs devices, aimed at assessing their quality and performance. The comprehensive document includes protocols for various IVD types and serves as a foundation for issuing IVD licenses in India, inviting stakeholder feedback to refine the regulatory framework.

• August 2024: Sysmex India strengthened its footprint by establishing state-of-the-art reagent manufacturing facilities and shifting from distribution partnerships to direct operations, enhancing product availability, ensuring supply chain stability, and improving customer support across the country.

Emerging Trends in the India In Vitro Diagnostics Market:

• Rapid adoption of molecular diagnostics, including PCR, NGS, and CRISPR-based platforms, enabling highly accurate pathogen and genetic testing.

• Growing integration of AI and machine learning in diagnostic systems to improve precision and reduce interpretation time.

• Rising burden of chronic diseases (diabetes, CVD, cancer) driving demand for early detection and advanced biomarker testing.

• Post-pandemic infrastructure boosts continued uptake of molecular and infectious disease diagnostics across India.

• Strong surge in point-of-care (POC) molecular devices, improving bedside and remote-area testing accessibility.

• Expansion of diagnostic access through district-level government labs and private hub-and-spoke chains.

• Emerging technologies such as digital PCR, microfluidics, and isothermal amplification making advanced diagnostics more affordable and portable.

Market Scope and Growth Factors:

• PLI scheme for medical devices accelerating domestic manufacturing and reducing import reliance.

• Joint ICMR-CDSCO standardized IVD evaluation protocols enhancing product quality and global competitiveness.

• Strengthening diagnostic infrastructure under the National Health Mission, including district-level laboratories.

• Rising prevalence of both communicable and non-communicable diseases boosting demand for early and routine diagnostics.

• Increasing health insurance coverage and disposable incomes improving affordability and test uptake.

• Rapid expansion of organized diagnostic chains into tier-2 and tier-3 cities, increasing test accessibility by over 20%.

• Growing adoption of automation, AI-based testing workflows, LIS integration, and telepathology, improving efficiency and scalability.

• Increased focus on local manufacturing, improving supply chain stability and product availability across regions.

Comprehensive Market Report Highlights & Segmentation Analysis:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest India In Vitro Diagnostics Market Share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments.

Segmentation by Test Type:

• Clinical Chemistry
• Molecular Diagnostics
• Immunodiagnostics
• Hematology
• Others

Segmentation by Product:

• Reagents and Kits
• Instruments

Segmentation by Usability:

• Disposable IVD Devices
• Reusable IVD Devices

Segmentation by Application:

• Infectious Disease
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Others

Segmentation by End User:

• Hospitals Laboratories
• Clinical Laboratories
• Point-of-care Testing Centers
• Academic Institutes
• Patients
• Others

Segmentation by Region:

• North India
• West and Central India
• South India
• East and Northeast India

Competitor Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Buy the Latest 2026 Edition: https://www.imarcgroup.com/checkout?id=21465&method=1337

Key highlights of the Report:

• Historical Market Performance
• Future Market Projections
• Impact of COVID-19 on Market Dynamics
• Industry Competitive Analysis (Porter's Five Forces)
• Market Dynamics and Growth Drivers
• SWOT Analysis (Strengths, Weaknesses, Opportunities, Threats)
• Market Ecosystem and Value Creation Framework
• Competitive Positioning and Benchmarking Strategies

Major Advantages of the Report:

• This report provides market leaders and new entrants with accurate revenue estimates for the overall market and its key subsegments.
• Stakeholders can leverage this report to gain a deeper understanding of the competitive landscape, enabling them to strategically position their businesses and develop effective go-to-market strategies.
• The report provides stakeholders with valuable insights into the market dynamics, offering a comprehensive analysis of key drivers, restraints, challenges, and opportunities.

Get Your Customized Market Report: https://www.imarcgroup.com/request?type=report&id=21465&flag=C

Note: If you require specific information not included in the current report, we are pleased to offer customization options to meet your needs.

Explore More Reports & Get Your Free Sample Now!

• India Reinsurance Market: https://www.imarcgroup.com/india-reinsurance-market/requestsample

• India Organ Preservation Market: https://www.imarcgroup.com/india-organ-preservation-market/requestsample

• India Microinsurance Market: https://www.imarcgroup.com/india-microinsurance-market/requestsample

• India Building Facade Market: https://www.imarcgroup.com/india-building-facade-market/requestsample

• India Athleisure Market: https://www.imarcgroup.com/india-athleisure-market/requestsample

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: +1-201971-6302 | Africa and Europe: +44-702-409-7331

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.